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71. INTRODUCTION
Escherichia coli is the predominant facultative anaerobic bacterium in the human colonic flora. It
usually remains harmlessly confined to the intestinal lumen; however, in the debilitated or
immunosuppressed host, or when gastrointestinal barriers are violated, even E. coli strains of
normal flora can cause infection. Three general clinical syndromes result from infection with
pathogenic E. coli strains: (i) urinary tract infection; (ii) sepsis/meningitis; and (iii) enteric/diarrhoeal
disease (Nataro and Kaper 1998). This thesis concentrates on the diarrhoeagenic E. coli strains,
which include several emerging pathogens of worldwide public health importance.
Contaminated food and water are important vehicles for transmission of various enteric pathogens.
The food industry, restaurants and private homes occasionally fail to meet adequate cooling,
storage, preparation and other hygiene standards, and food may be contaminated with faecal flora
due to improper practices of those who prepared the food. This makes possible the distribution of
enteric pathogens and the spread of diseases caused by them. Among enteric pathogens,
diarrhoeagenic E. coli belong to the most common bacteria causing intestinal infections in both
developing and industrialised countries.
Diarrhoeagenic E. coli have been classified into different categories according to their special
characteristics. Enteropathogenic E. coli (EPEC) has been linked to infant diarrhoea in developing
countries. They were previously commonly found also in industrialised countries and, were known
as "dyspepsiekoli." Enterotoxigenic E. coli (ETEC) has been regarded as the most common
pathogen causing tourist diarrhoea (TD), irrespective of destination. Enteroaggregative E. coli
(EAEC) and Shiga toxin-producing E. coli (STEC) are new E. coli pathogroups. The former have
been implicated as one of the aetiological agents of diarrhoea both in developing countries and in
outbreaks of gastro-enteritis in industrialised countries. STEC strains are well-known causes of
bloody diarrhoea and haemorrhagic colitis (HC) in humans.
Diarrhoeagenic E. coli were among the first pathogens for which molecular diagnostic methods
were developed. Molecular methods, especially polymerase chain reaction (PCR), are nowadays
considered the most reliable techniques for differentiating diarrhoeagenic E. coli strains from
8nonpathogenic members of the stool flora and for distinguishing one E. coli pathogroup from
another (Nataro and Kaper 1998). This has made it possible to re-evaluate the role of various
diarrhoeagenic E. coli groups in diarrhoea in humans.
92. REVIEW OF THE LITERATURE ON DIARRHOEAGENIC E. COLI
2.1 Microbial diarrhoea
Diarrhoea associated with bacterial, viral or parasitic infections is the most common infectious
illness experienced by millions of children in developing countries, and also the major cause of
disease in international travellers. According to the World Health Organization (WHO 1993), 16
million deaths were due to infectious diseases in 1990. Of these deaths, diarrhoea accounted for
over 3 million. The main examples of diarrhoeal disease associated with bacteria are cholera and
diarrhoea due to ETEC. Cholera remains an important cause of illness in many developing
countries and has been estimated to result in more than 120 000 deaths each year. In children in
developing countries, ETEC is responsible for more than 650 million diarrhoeal episodes and 800
000 deaths annually (Cravioto et al. 1998). However, diarrhoea as a syndrome is not limited to
developing countries.
The most readily recognised bacterial agents of gastroenteritis in industrialised countries are
Salmonellae and Campylobacter (Murray et al. 1995). Moreover, acute diarrhoea may be
associated with a large number of other bacteria, such as Yersinia enterocolitica,
Staphylococcus aureus and Bacillus cereus. The various Shigellae can cause diarrhoea or the
syndrome known as bacillary dysentery. In particular, incompletely prepared or incompletely
heated food has been reported as the source of different diarrhoeal pathogens.
Additionally, other organisms such as parasites and viruses are common causes of diarrhoea
around the world. Entamoeba histolytica and Giardia lamblia are usually acquired by ingestion
of food or water contaminated with faeces (Murray et al. 1995). Usually no symptoms result from
the presence of these parasites in the colon, but some people experience abdominal pain and
diarrhoea. Rotaviruses are a common cause of diarrhoeal disease in the whole world (Murray et al.
1995). Recently, caliciviruses have caused large diarrhoea outbreaks in industrialised countries. In
Finland, caliciviruses have spread via drinking water and frozen berries (Kukkula 1998).
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2.2 Isolation, identification and common themes in virulence of E. coli
E.  coli is the type species of genus Escherichia which contains mostly motile gram-negative bacilli
within the family Enterobacteriaceae and the tribe Escherichia. The most highly conserved
feature of diarrhoeagenic E. coli strains is their ability to colonise the intestinal mucosal surface
despite peristalsis and competition for nutrients (Nataro and Kaper 1998). The presence of
surface adherence fimbriae is a property of virtually all E. coli strains. However, diarrhoeagenic E.
coli strains possess specific fimbrial antigens that enhance their intestinal colonising ability and allow
adherence to the small bowel mucosa, a site that is not normally colonised (Levine et al. 1984).
Three general paradigms have been described by which E. coli may cause diarrhoea; each is
described in more detail in the appropriate section below: (i) enterotoxin production (ETEC and
EAEC); (ii) invasion (Enteroinvasive E. coli (EIEC)); and (iii) intimate adherence with membrane
signalling (EPEC and STEC). However, the interaction of the organisms with the intestinal mucosa
is specific for each category (Nataro and Kaper 1998).
The versatility of the E. coli genome is conferred mainly by two genetic configurations: virulence-
related plasmids and chromosomal pathogenicity islands. STEC, EPEC, EAEC and EIEC strains
typically harbour highly conserved plasmid families, each encoding multiple virulence factors
(Nataro and Kaper 1998). Chromosomal virulence genes of STEC and EPEC are organised as a
cluster referred to as a pathogenicity island (McDaniel et al. 1995).
2.2.1 Diagnostics
E. coli can be recovered from clinical specimens on general or selective media at 37ºC under
aerobic conditions. E. coli in stools are most often recovered on MacConkey- or Eosin
methylene-blue agar, which selectively grow members of the Enterobacteriaceae and permit
differentiation of enteric organisms on the basis of their morphology (Murray et al. 1995).
Identification of diarrhoeagenic E. coli strains requires that these organisms can be differentiated
from non-pathogenic members of the normal flora. Substantial progress has been made in the
development of nucleic acid-based technologies. The use of DNA probes for detection of heat-
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labile (LT) and heat-stable (ST) enterotoxins in ETEC revolutionised the study of these organisms
by replacing the awkward and costly animal models of toxin detection (Mosley et al. 1982). Since
then, gene probes have been introduced for all diarrhoeagenic E. coli categories. Another widely
used method is Polymerace Chain Reaction (PCR). It has been a major advance in molecular
diagnostics of pathogenic microorganisms, including E. coli. In PCR, a pair of primers (20-40
bases) is used for selective amplification and detection of a certain DNA sequence in a target
organism. PCR primers have successfully been developed for all categories of diarrhoeagenic E.
coli. PCR can be used in both diagnosing and typing E. coli strains. Advantages of PCR include
high sensitivity, spesificity and appropriate rapidity in the detection of target DNA templates.
However, substances within stools have been shown to interfere with PCR (Stacy-Phipps et al.
1995). However, PCR has been found beneficial in diagnosing diarrhoeagenic E. coli. Recently, it
was concluded that PCR detects significantly more ETEC infections than does the standard probe-
based hydridisation method (Caeiro et al. 1999). In diagnostics, PCR is commonly used for
detecting different virulence associated genes of E. coli, such as toxin and adherence associated
genes (Table 1). PCR is also widely used in subtyping by doing virulence gene profiles for different
diarrhoeagenic E. coli strains.
Other methods specifically capable of detecting certain types of E. coli have been developed,
especially for STEC. The latex agglutination test (Verotox-F assay, Denka Seyken, Tokio, Japan)
for detection of toxins produced by STEC has been found 100% sensitive and 100% specific in
comparison with the classical Vero cell assay (Karmali et al. 1999). Immunomagnetic separation
with magnetic beads coated with antibody against E. coli O157 have been found more sensitive
than direct culture of these strains (Chapman and Siddons 1996).
2.2.2 Serotyping
Prior to the identification of specific virulence factors in diarrhoeagenic E. coli strains, serotypic
analysis was the predominant means by which pathogenic strains were differentiated. In 1947,
Kauffmann proposed a scheme for the serologic classification of E. coli (Kauffmann 1947), which
is still used in a modified form today. According to the modified Kauffmann scheme, E. coli are
now serotyped on the basis of their O (somatic), H (flagellar), and K (capsular) surface antigens
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(Ørskov and Ørskov 1984). However, generally only extraintestinal E. coli are encapsulated (Jann
and Jann 1992). Thus, among diarrhoeagenic E. coli, usually a specific combination of O and H
antigens defines the serotype of the strain. E. coli of specific serogroups can be associated with
certain clinical syndromes (Table 1), but it is not in general the serologic antigens themselves that
confer the virulence (Ørskov and Ørskov 1984).
2.2.3 Genotyping
In recent years, the use of molecular “fingerprinting” methods has become standard practice in
microbiology for evaluating the epidemiology of infectious diseases, investigating suspected
outbreaks of bacterial infections, and typing bacteria (Mickelsen 1997). Pulsed-field gel
electrophoresis (PFGE) allows the generation of simplified chromosomal restriction fragment
patterns without having to resort to probe hydridisation methods. In this method, restriction
enzymes that infrequently cut DNA are used for generating large fragments of chromosomal DNA,
which are then separated by special electrophoresis (Swaminatham and Matar 1993). PFGE has
been applied to subtyping of several gram-positive and gram-negative bacteria. It is now widely
used in epidemiological surveillance and common interpretation schemes have been published
(Tenover et al. 1997). In 1995, the Centers for Disease Control and Prevention (CDC) in the
USA initiated PulseNet, a national computer network of public health laboratories that employs
standard methods to subtype STEC O157:H7 strains. Laboratories within the network can
transmit PFGE patterns electronically to a databank at the CDC, where they are automatically
compared with patterns of other isolates. If the patterns submitted by laboratories in different
locations during a defined time period are found to match, the CDC computer will alert PulseNet
participants of a possible multistate outbreak (Centers for Disease Control 2001).
Ribotyping is a method based on DNA probes that recognize conserved RNA operon genes.
Ribotyping is essentially a Southern blot analysis in which strains are characterised for restriction
fragment length polymorphism of their individual ribosomal genes. Within a species, and particularly
within a strain, the DNA sequences and the restriction digest patterns of genes encoding rRNA are
highly conserved and thus serve as a molecular fingerprint for that organism. All organisms have
ribosomal genes. This technique is universally applicable and has also found acceptance as a
13
clinical tool for typing E. coli (Tarkka et al. 1994). All these new molecular typing methods have
allowed highly discriminant genotyping, and are useful tools for demonstrating that isolates from
different sources are identical, closely related or not related at all (Mickelsen 1997).
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Table 1. Characteristics of the diarrhoeagenic E. coli
Category Characteristic serogroups 1) Virulence determinants2) Main targets in
diagnostics2)
Published molecular detection
methods
Characteristic O serotypes Toxins Other
STEC O5, O22, O26, O55, O91,
O103, O111, O113, O117,
O118, O128, O145, O157
Stx1, Stx2,
EAST1, Ehly
A/E, LEE stx1, stx2 Olsvik and Strockbine 1993 (PCR)
Fratamico et al. 1995 (PCR)
Paton and Paton 1999 (PCR)
Cocolin et al. 2000 (PCR)
EPEC O26, O55, O86, O111,
O114, O119, O125, O126,
O128, O142, O158
EAST1 A/E, EAF,
BFP, LEE
eae, EAF-
plasmid, bfpA,
Jerse et al. 1990 (probe)
Gannon et al. 1993 (PCR)
Heuvelink et al. 1995 (PCR)
Batchelor et al. 1999 (PCR)
Cocolin et al. 2000 (PCR)
EAEC O3, O15, O44, O77, O86,
O111, O127
EAST1 AA EA-plasmid Baudry et al. 1990 (probe)
Schmidt et al. 1995 (PCR)
ETEC O6, O8, O25, O78, O126,
O148, O153, O169
LT, ST,
EAST1
CFAs elt, etx Murray et al. 1987 (probe)
Frankel et al. 1989 (PCR)
Olsvik and Strockbine 1993 (PCR)
Schultz 1994 (PCR and probe)
Yavzori et al. 1998 (PCR)
1) The information presented is derived from several publications (Robins-Browne 1987, Wolf 1997, Nataro and Kaper 1998, Law and Chart 1998,
Bettelheim 2000). 2) See the text for abbreviations and discussion
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2.3 Shiga toxin-producing E. coli (STEC)
The recognition of STEC as a distinct class of pathogenic E. coli resulted from two
epidemiological observations. The first was the report of Riley et al. in 1983, who investigated two
outbreaks characterised by severe abdominal pain and watery diarrhoea followed by bloody
diarrhoea. This illness, designated as HC, was associated with the ingestion of undercooked
hamburgers at a fast food restaurant chain. Stool cultures from these patients yielded a previously
rare E. coli serotype O157:H7. The second essential observation, also in 1983, was by Karmali et
al. (1983) who reported the association of sporadic cases of Haemolytic Uraemic Syndrome
(HUS) with faecal cytotoxin and cytotoxin producing E. coli in stools. Thus, the two clinical
microbiological observations, one based on a rare E. coli serotype and the other on the production
of a specific cytotoxin, led to the recognition of a novel and increasingly important class of enteric
pathogens causing intestinal and renal disease.
2.3.1 Nomenclature
The discovery of this pathogen along distinct paths of investigation resulted in a parallel
nomenclature, a situation that still exists. The term Verotoxigenic E. coli or Vero cytotoxin-
producing E. coli (VTEC) was derived from the observation that these strains produced a toxin
that was cytotoxigenic for Vero cells (Konowalchuk et al. 1977). The term VTEC is still widely
used in the United Kingdom and in many European scientific publications. The term
enterohaemorrhagic E. coli (EHEC) was originally coined to denote strains that cause HC and
HUS (Nataro and Kaper 1998). According to the latest nomenclature, these strains are called
Shiga toxin-producing E. coli (STEC) (formerly Shiga like toxin-producing E. coli (SLTEC), a
term that reflects the cytotoxin produced by these strains (Calderwood et al. 1997). The term
STEC is used especially in American scientific papers.
STEC and VTEC are equivalent terms, and both refer to E. coli strains that produce one or more
cytotoxins. However, it is not clear that mere possession of toxin genes confers pathogenicity in the
absense of other virulense factors (see below). Strains carrying toxin genes are commonly found
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from many healthy domestic animals. However, these strains often lack some, or all, other
virulence determinants often connected with STEC (Beutin et al. 1995). Thus, all STEC are not
believed to be pathogens, whereas all EHEC are (Nataro and Kaper 1998). However, other types
of diarrhoeagenic E. coli can also cause bloody diarrhoea. Usage within the scientific world will
determine the final name(s) of these strains, and whether one or all of the names will be used.
2.3.2 Shiga toxins (Stx) and other factors affecting the pathogenic properties of STEC
STEC strains produce Stx toxins, also known as Vero toxins (VT) or Shiga-like toxins (Slt). Stx
toxin is essentially identical at the genetic and protein levels to the Stx-toxin produced by Shigella
dysenteriae 1. The Stx family contains two major, immunologically non-cross-reactive groups
called Stx1 and Stx2, encoded by the stx1 and stx2  genes. Both toxins are composed of five B
subunits (encoded by stxB) and a single A subunit (encoded by stxA) and both, stxA and stxB,
are located on a temperate bacteriophage inserted into the STEC chromosome. Genes involved in
STEC pathogenesis are presented in Figure 1 (Nataro and Kaper 1998). A single STEC strain
may express Stx1 only, Stx2 only, or both toxins, or even multiple forms of Stx2. The prototypical
Stx1 and Stx2 toxins, respectively, have 55% and 57% sequence identity in A and B subunits,
(Jackson et al. 1987). While Stx1 is highly conserved, sequence variation exists in Stx2. Three
types of Stx2 have been identified: Stx2, Stx2c and Stx2e (Pierard et al. 1998). The subtype
Stx2e is classically associated with pig oedema disease rather than human disease, but occasional
strains that express only this variant are isolated from patients with HUS (Thomas et al. 1994). The
various subtypes are wholly interchangeable between the Stx and VT nomenclatures (i.e.
Stx1=VT1=Slt1, Stx2e=VT2e=Slt2e etc.) (Caldervood et al. 1997). Most molecular diagnostic
methods for STEC are aimed at the detection of genes encoding Stx (Olsvik and Strockbine 1993,
Cocolin et al. 2000). Improved diagnostics have increased the variety of STEC types found in
patients with HC or some other STEC associated disease, and new clones continue to emerge, for
example Stx2-producing STEC O26:H11 found in Germany (Zhang et al. 2000).
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Figure 1. Genes involved in STEC (i.e. EHEC, see 2.3.1) pathogenesis. Genes involved in STEC
pathogenesis are similar to those implicated for EPEC, excecpt for the presence of the Stx-
encoding phage on the STEC chromosome and the presence of the characteristic STEC 60-MDa
plasmid instead of the EAF plasmid of EPEC (adapted from Nataro and Kaper 1998).
Other virulence associated factors of STEC are the production of enterohaemolysin (Ehly) and,
possibly, heat-stable enterotoxin (EAST1). Genes encoding Ehly are located in the 60-MDa
plasmid found in nearly all O157:H7 strains and also widely in non-O157 STEC strains. In
Germany, approximately 90% of all STEC strains isolated from patients possessed genes encoding
Ehly (Beutin et al. 1994). However, the significance of Ehly production as a true virulence factor is
hard to judge, since in a study by the same author, the Stx-negative and Ehly-positive E. coli were
in vitro incapable of causing visible damage to Vero, Hep-2 or HeLa cells (Beutin et al. 1989).
EAST1, first described in EAEC, is also found in many STEC strains. The significance of EAST1
in the pathogenesis of STEC is unknown, but it migth account for some of the non-bloody
diarrhoea frequently seen in persons infected with STEC (Nataro and Kaper 1998).
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The only potential STEC adherence factor that has been demonstrated as playing a role in intestinal
colonisation is the 94-97 kDa outer membrane protein intimin. It is encoded by the eae gene and
produces extensive attaching-and-effacing (A/E) lesions in the large intestine, featuring intimate
adherence of the bacteria to the epithelial cells (Donnerberg et al. 1993b). This eae gene is also
found in EPEC. The eae is only one of many genes located on the 35 kb pathogenicity island
called the locus of enterocyte effacement (LEE), which confers the A/E phenotype for EPEC. The
STEC LEE contains genes encoding intimin, translocated intimin reseptor (Tir), the secreted
proteins EspA and EspB, and a type III secretion pathway. Formation of A/E lesions depends
upon interaction between bacterial outer membrane protein (intimin) and bacterially encoded
reseptor protein Tir, which is exported from the bacterium and translocated into the host cell
membrane (Paton et al. 1998). The true roles of EspA and EspB are unknown, but type III
secretion systems are responsible for secretion and translocation of critical virulence determinants
found in a variety of gram-negative human, animal, and plant pathogens (Jarvis and Kaper 1996).
However, all STEC do not carry eae. Thus, it has also been suggested that intimate bacterial
attachment and induction of extensive A/E lesions have only slight effect on the uptake of Stx2
producing STEC to cause the disease (Tzipori et al. 1995).
Most STEC outbreaks have been caused by O157:H7 strains, suggesting that this serotype is in
some way more virulent or more transmissible than other serotypes. The unique biochemical
marker for this group is that most STEC O157:H7 strains cannot ferment sorbitol or produce β-
glucuronidase. Thus, in many countries the STEC diagnostics are based on the detection of
sorbitol-negative STEC O157:H7 strains only. However, most E. coli strains of normal flora,
including pathogenic non-O157 STEC strains, can ferment sorbitol and produce β-glucuronidase.
Moreover, E. coli strains belonging to over 200 serotypes can express Stx, but within most
serotypes, both Stx-positive and Stx-negative strains can be found (Johnson et al. 1996). More
than 100 of these serotypes have been associated with HC or HUS in humans. The most common
non-O157 serotypes associated with human disease include O26:H11, O103:H2, O111:HNM
and O113:H21 (WHO 1994).
Non-bloody diarrhoea, HC and HUS or TTP (thrombotic thrombocytopenic purpura) are the
most common symptoms STEC can cause, although the infection may also be lethal. Additionally,
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a large number of other complications may arise and they include cholecystis, colonic perforation,
pancreatitis, posthemolytic biliary lithiasis, postinfectious colonic stricture, rectal prolapse,
appendicitis, hepatitis, haemorrhagic cystitis, pulmonary oedema, myocardial dysfunction, and
neurological abnormalities (Griffin 1995, Tarr 1995). The frequencies of the various syndromes
include about 10% non-bloody diarrhoea, 90% HC, and 10% HUS/TTP. Additionally, < 5% are
associated with different intestinal and extraintestinal complications (Tarr 1995).
2.3.3 Sources of STEC infections
STEC can be found in the faecal flora of a variety of animals including cattle, sheep, goats, pigs,
cats and dogs (Beutin et al. 1993, Beutin et al. 1995, Chapman et al. 1997), horses (Chalmers et
al. 1997) and even seagulls (Makino et al. 2000). The most important animal species in terms of
human infection is cattle, but the prevalence of STEC O157:H7 in cattle varies significantly from
country to country. Surveys of bovine cattle have found STEC O157:H7 in 1.3% of animals in
Finland (Lahti et al. 2001), 10.8% in Germany (Montenegro et al. 1990), and 15.7% in the United
Kingdom (Chapman et al. 1997). STEC strains are usually isolated from healthy animals, but may
be associated with an initial episode of diarrhoea in young animals followed by asymptomatic
colonisation. The STEC O157:H7 isolation rates from animals are much lower than those of non-
O157 serotypes. The main route of STEC into the food chain is through contamination of meat by
intestinal contents and faeces in the abattoir (Butler 1996).
Usually STEC are transmitted to humans by food, water, and from person to person. Most cases
are caused by ingestion of contaminated foods, particularly foods of animal origin, beef being a
major vehicle of infection. In the United States, ingestion of undercooked hamburgers, prepared in
a restaurant or at home, has been a particularly significant cause of outbreaks (Griffin 1995). In
Japan, the largest reported STEC outbreak, where over 6000 people were infected and 13 died,
was associated with centrally distributed school food (National Institute of Health... 1996). In
Scotland, over 400 people were infected with, and 18 elderly patients died of, infections
associated with a butcher’s shop and contaminated meat products (Christie 1997). However, the
spectrum of vehicles implicated in disease due to STEC is expanding beyond the initial hamburger-
associated outbreaks. STEC outbreaks have been linked to consumption of different foods, such
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as mayonnaise (Griffin 1995) unpasteurised apple juice (McCarthy 1996), alfalfa sprouts (Centers
for Disease Control 1995a) and fermented hard salami (Centers for Disease Control 1995b).
These vehicles illustrate the notable ability of STEC to grow in foods under conditions where other
pathogens would not survive. Molecular subtyping methods, especially PFGE, have been
extensively used to distinguish between outbreak-associated and sporadic or unrelated O157:H7
infections (Bender et al. 1997). However, while the large STEC outbreaks involving hundreds of
individuals have garnered the most attention, sporadic infections comprise the major burden of this
pathogen (Lansbury and Ludlam 1997).
2.4 Enteropathogenic E. coli (EPEC)
During the 1920s in Germany, Adam showed by serologic typing that strains of “dyspepsiekoli”
could be implicated in outbreaks of paediatric diarrhoea (Adam 1923). In 1955, the term
enteropathogenic E. coli was first coined by Neter et al. (1955) to indicate those strains of E. coli
that had been epidemiologically linked with childhood diarrhoea. It was defined for decades solely
on the basis of O and H serotypes found typically in diarrhoeal children younger than two years
(Robins-Browne 1987). However, this definition has changed drastically in recent years as
knowledge of this organism has increased. EPEC is still an important category of diarrhoeagenic E.
coli, which then was linked to infant diarrhoea in industrialised countries and now in the developing
world. Citing recent pathogenic data, the Second International Symposium on EPEC in 1995
reached a consensus on the basic characteristics of EPEC, and now EPEC is defined on the basis
of molecular pathogenic characteristics (Kaper 1995).
2.4.1 Attaching-and-effacing (A/E) adherence of EPEC strains
According to a recent resolution, a diarrhoeagenic E. coli that produces a characteristic
histopathology known as attaching-and-effacing (A/E) and does not produce Shiga toxins can be
called EPEC (Kaper 1995). Genes involved in EPEC pathogenesis are similar to those implicated
for STEC (Table 1), except for the Stx-encoding phage on STEC chromosome and the presence
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of some other proposed virulence determinants found in STEC (Nataro and Kaper 1998). The
A/E lesion is characterised by intimate adherence between bacteria and epithelial cells and
effacement of intestinal microvilli. A/E can be observed in intestinal biopsy specimens from patients
or infected animals (Knutton et al. 1987). The gene necessary for mediating A/E has been
identified and termed eae. The eae gene codes for a protein called intimin, which is required for full
virulence of EPEC (Donnerberg et al. 1995a). Similar A/E lesions are seen in animal and culture
models of many STEC strains and Hafnia alvei isolated from children with diarrhoea (Albert et al.
1992). The overall pattern for these eae sequences from different bacteria shows high conservation
in the N-terminal region and variability in the C-terminal region (Nataro and Kaper 1998). The
role of intimin in human disease was demonstrated by studies on volunteers, who ingested an
isogenic eae negative mutant of EPEC E2348/69 (O127:H6). Diarrhoea was seen in all volunteers
who ingested the wild-type E2348/69 compared with four of 11 volunteers who ingested the
isogenic mutant. (Donneberg et al. 1995a).
A secreted enterotoxin that would explain the mechanism of diarrhoea due to EPEC has been
unsuccesfully sought for over many years (Robins-Browne et al. 1982, Nataro and Kaper 1998).
In the absence of recognised enterotoxins, attempts to develop improved diagnostic tests for
EPEC have centred on their adherence properties. In one EPEC strain (E2348/69), production of
a plasmid called EPEC adherence factor (EAF) was found necessary for adherence in a localized
pattern, and a 1-kb fragment from this region was developed as a diagnostic DNA probe (Baldini
et al. 1983). However, the possessing of EAF plasmids seems to occur only in some EPEC
serovars (class 1 EPEC) (Nataro et al. 1985, Tamura et al. 1996). PCR primers have been
developed to detect the eae gene of EPEC (Gannon et al. 1993, Heuvelink et al. 1995, Batchelor
et al. 1999). Subsequent studies have revealed that genes involved in adherence are required for
expression and assembly of bundle-forming pilus (BFP). BFP are fimbriae, encoded by bfpA in
EAF plasmid, and they also have a role in EPEC adherence (Donnerberg et al. 1992).
2.4.2 Epidemiology of EPEC infections
As with other diarrhoeagenic E. coli, transmission of EPEC is fecal-oral, with contaminated hands,
contaminated food, or contaminated fomites serving as vehicles. In adult outbreaks, waterborne
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and foodborne transmission has been reported, but no particular type of food has been implicated
as more likely to serve as a source of infection (Levine and Edelman 1984). The most notable
feature of the epidemiology of disease due to EPEC is the striking age distribution seen in persons
infected with this pathogen. EPEC infection is primarily a disease of infants younger than 2 years.
Illness caused by EPEC is often clinically acute, severe diarrhoea. The reason(s) for the relative
resistance of adults and older children is not known, but loss of specific receptors with age is one
possibility. However, EPEC can cause diarrhoea in an adult if the bacterial inoculum is high
enough. The infectious dose in naturally transmitted infection in infants is not known, but it is
presumed to be much lower than with adults. (Nataro and Kaper 1998).
Although several outbreaks of diarrhoea due to EPEC have been reported in healthy adults in
industrialised countries (Costin et al. 1964, Schroeder et al. 1968, Viljanen et al. 1990, Hedberg
et al. 1999), very little is known about the current status of EPEC as a diarrhoeagenic agent, since
it has no longer been routinely assayed from stool samples. In a recent study in the USA, EPEC
was detected with a DNA probe in 3.6% of children’s diarrhoeal samples and exceeded the rates
of Salmonella or Campylobacter (Bokete et al. 1997).
In contrast to the limited importance of EPEC in industrialised countries, EPEC is a major cause of
infant diarrhoea in developing countries (Nataro and Kaper 1998). Studies in Brazil (Gomes et al.
1989), Mexico (Cravioto et al. 1988), and South Africa (Robins-Browne et al. 1982) have shown
that 30-40% of infant diarrhoea can be attributed to EPEC. EPEC strains are an important cause
of disease in all settings of nosocomial outbreaks, outpatient clinics, patients admitted to hospitals,
community-based longitudinal studies, and urban and rural settings (Nataro and Kaper 1998).
2.5 Enteroaggregative E. coli (EAEC)
EAEC, often also EaggEC, has been epidemiologically implicated as one of the etiological agents
of diarrhoea in industrialised and developing countries. The group is heterogenous, comprising a
diverse range of serotypes that possess a variety of putative virulence factors (Law and Chart
1998).
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2.5.1 Aggregative adhesion (AA) and other proposed virulence characteristics
EAEC strains are currently defined as E. coli strains that do not secrete enterotoxins LT or ST and
that adhere to HEp-2 cells in an aggregative adhesion (AA) pattern (Baydry et al. 1990). The
pathogenesis and the site of EAEC infection in the human intestine are not well understood.
However, a characteristic histopathologic lesion and several candidate virulence factors have been
described. Virtually all EAEC strains carry a 60 Mda plasmid that contains a gene that confers AA
and a gene that encodes EAEC heat-stable enterotoxin-1 (EAST1). However, the role of EAST1
in diarrhoea has not yet been determined, although EAST1 clones yield net increases in short-
circuit current in the rabbit mucosa when the chamber model is used (Savarino et al. 1991). Other
virulence associated factors have been proposed. These include putative haemolysins and toxins,
and various types of fimbriae and outer membrane proteins that may be involved in the adhesion
process (Law and Chart 1998). The role of these factors and mechanisms by which EAEC adhere
to eukaryotic cells have not been identified, but carriage of plasmid-encoded gene encoding AA is
essential (Baydry et al. 1990).
Diagnosis of EAEC infection is problematic; serotyping cannot identify strains of E. coli expressing
the EAEC phenotype. Currently, EAEC are identified by either cell adhesion tests or DNA-based
tests involving gene probes or PCR for detecting the plasmidial genes encoding cell adhesion, but
these methods cannot be used in a routine clinical laboratory (Law and Chart 1998).
2.5.2 Diarrhoea caused by EAEC
A growing number of studies have supported the association of EAEC with diarrhoea, most
prominently with persistent diarrhoea (>14 days). In most studies conducted in recent years,
EAEC have been detected either with PCR (Schmidt et al. 1995) or with a DNA probe (Baydry
et al. 1990). Although most reports have implicated EAEC in sporadic endemic diarrhoea, an
increasing number of reports have described EAEC also in outbreaks. In Brazil, EAEC has been
detected in up to 68% of persistent diarrhoea cases (Fang et al. 1995). In India, EAEC have been
associated with persistent diarrhoea (Bhan et al. 1989a) and cases of sporadic diarrhoea detected
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in household surveillance (Bhan et al. 1989b). Interestingly, in Brazil, the isolation of EAEC from
the stools of infants was associated with a significantly lower height and/or weight of the EAEC
carriers than the mean of the populations, irrespective of the presence of diarrhoael symptoms
(Steiner et al. 1998).
In industrialised countries, very little is known about the epidemiology of EAEC. However, it has
been reported that in Germany 2% of children with diarrhoea have EAEC in their stools (Hubberz
et al. 1997). In Austria, EAEC was the most common E. coli group found in patients with diarrhea
(Presterl et al. 1999). In Japan in 1993, EAEC ONT:H10 caused a large outbreak where 2 697
schoolchildren developed severe diarrhoea (Itoh et al. 1997). In the United Kingdom, four
outbreaks of diarrhoea have been reported as being due to EAEC strains representing several
different serotypes (O19, O62, O73, O86, O113, O116, O125, O134). Each of the outbreaks
was associated with consumption of a restaurant meal, but no single source could be implicated
(Smith et al. 1997). In another British study, EAEC were the most common diarrhoeagenic E. coli
group detected in diarrhoeal patients (Tompkins et al. 1999). In the United States and Switzerland,
EAEC have been linked with diarrhoea in human immunodeficiency virus-infected patients (Mayer
and Wanke 1995, Durrer et al. 2000).
2.6 Enterotoxigenic E. coli (ETEC)
ETEC strains are an important world-wide cause of diarrhoeal disease in humans, mainly affecting
children in developing countries and travellers going from industrialised countries to less developed
countries. It was DuPont et al. (1971) who first showed that ETEC strains were capable of
causing diarrhoea in adult volunteers. In general, ETEC strains are considered to represent a
pathogenic prototype: the organism colonises the surface of the small bowel mucosa and
elaborates their enterotoxins, giving rise to secretion of electrolytes and water (Nataro and Kaper
1998).
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2.6.1 Heat-stable (ST) and heat-labile (LT) enterotoxin production and other virulence
associated factors
ETEC is defined as E. coli strains that produce at least one of the two defined groups of
enterotoxins: ST and LT enterotoxins (Levine 1987). Thus, detection of ETEC has long relied on
detection of the enterotoxins. The use of DNA probes for detection of LT and ST enterotoxins in
ETEC revolutionised the study of all diarrhoeal organisms by replacing the awkward and costly
animal models of toxin detection (Mosley et al. 1982).
LTs are large oligomeric toxins that are closely related in structure and function to the cholera toxin
(CT) expressed by Vibrio cholerae. The two immunotypes of LT, LT-I and LT-II, share the
same ganglioside receptor and mode of action, but are antigenically distinct (Sixma et al. 1993).
The genes encoding LT (elt or etx) reside on plasmids that may also contain genes encoding ST
and/or colonisation factor antigens (CFAs) (Nataro and Kaper 1998). In contrast to LTs, the STs
are small, monomeric toxins that contain multiple cysteine residues, whose disulphide bonds
account for the heat stability of these toxins (Nataro and Kaper 1998). ST is not a single toxin but
a family of small toxins that fall into two subgroups (methanol soluble) STa (or STI) and (methanol
insoluble) STb (or STII), which differ in nucleotide and amino acid sequences (Salyers and Whitt
1994). Besides the production of LT and/or ST, some ETEC strains may also express EAST1
(Savarino et al. 1996), which was first found in EAEC.
ETEC strains have two major virulence determinants, enterotoxins and CFAs. To cause diarrhoea,
ETEC strains must first adhere to small bowel enterocytes, an event mediated by surface fimbriae.
ETEC adhere to epithelial surfaces by means of CFAs and putative colonisation antigens, jointly
referred as CFs. There exist three major morphologic varieties of CFs: rigid rods; bundle-forming
flexible rods; and thin flexible wiry structures. At least 20 different CFs in ETEC pathogenic to
humans have been described, but they are almost always encoded by plasmids also encoding ST
and/or LT enterotoxins (Gaastra and Svennerholm 1996). ETEC strains cause diarrhoea through
the action of these enterotoxins. Diarrhoea caused by ETEC has much in common with cholera;
both result from ingestion of rather large inocula of bacteria that will colonise in the small intestine
and produce toxins that cause net fluid secretion into the intestinal lumen. Typically, the diarrhoea is
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watery, usually without blood, but not severe, and it resolves without treatment in about a week. In
some cases, ETEC infection may result in severe purging similar to that seen in cholera (Arduino
and DuPont 1993).
2.6.2 Infant diarrhoea and tourist diarrhoea
Food and water are the most common vehicles for ETEC infection. Thus, faecal contamination is
the principal reason for the high incidence of ETEC infection throughout the developing world.
ETEC infections in areas of endemic infections tend to be clustered in warm, wet months, when
multiplication of ETEC in food and water is most efficient (Levine 1987). Sampling of both food
and water sources from areas of endemic ETEC have demonstrated strikingly high rates of ETEC
contamination (Ryder et al. 1976). Asymptomatic ETEC excretion is also commonly found (Abu-
Elyazeed et al. 1999). Thus, it is not surprising that, in developing countries, children under 2 years
of age typically have two to three episodes of diarrhoea per year, with ETEC infections
representing more than 25% of all these diarrhoeal cases, and contribute significantly to the
mortality of this group. Oral rehydration therapy is often lifesaving in infants and children with
ETEC diarrhoea (Black et al. 1981).
Although ETEC infection occurs most frequently in infants, immunologically naive adults are also
susceptible. Thus, ETEC has been regarded as the most common pathogen in TD, irrespective of
the tourist destination (Mattila 1995). The percentages of ETEC, however, have varied from study
to study, from nation to nation, and from season to season. Studies suggest that 20-60% of
travellers visiting areas where ETEC infection is endemic, experience diarrhoea; typically, 20-40%
of cases are believed to be due to ETEC (Arduino and DuPont 1993, Nataro and Kaper 1998).
Many studies have investigated the effect of dietary self-restrictions on the risk of TD. However,
the dietary self-restrictions have had no or only limited benefit (Loewenstein et al. 1973, Mattila
1995, Mattila et al. 1995). An oral cholera vaccine containing killed V. cholerae and purified
cholera toxin B subunit has been reported to provide some protection against TD due to ETEC
(Clemens et al. 1988, Peltola et al. 1991). This protection is presumably due to the structural and
antigenic similarity between LT and CT.
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2.7 Other groups of diarrhoeagenic E. coli
2.7.1 Enteroinvasive E. coli (EIEC)
EIEC strains are often biochemically atypical and difficult to identify. Antigenically, biochemically
and pathogenically these strains resemble Shigella so much that the illness caused by EIEC has
often been mistaken for shigellosis. Clinical features include fever, abdominal cramps, malaise,
toxaemia and watery diarrhoea or typical dysentery with blood, mucus and many faecal
leukocytes. Both Shigella spp. and EIEC have been shown to invade the colonic epithelium, a
phenotype mediated by both plasmid and chromosomal loci (Sansonetti 1992). In addition, both
have one or more secretory enterotoxins that may play roles in diarrhoeal pathogenesis (Nataro
and Kaper 1998). True prevalence of EIEC diarrhoea is not known. Endemic sporadic disease
occurs in some areas, generally where Shigella spp. are also prevalent, but the epidemiologic
features may be different from those of Shigella spp (Taylor et al. 1988). EIEC has also been
associated with diarrhoea occurring in travellers and with outbreaks of food poisoning due to
ingestion of contaminated food  (Pushker 1994).
2.7.2 Diffusely adherent E. coli (DAEC)
The term diffusely adherent E. coli (DAEC) was initially used to refer to any Hep-2-adherent E.
coli strain that did not form EPEC-like microcolonies. With the discovery of EAEC, most authors
now recognise DAEC as an independent category of potentially diarrhoeagenic E. coli (Nataro
and Kaper 1998). Little is known about the pathogenic features of DAEC induced diarrhoea and
no PCR assay has been described as identifying DAEC. Levine et al. (1993) showed that in
Santiago, Chile the relative risk of DAEC in association with diarrhoea increased with age from 1
to 4-5 years. The reason for such an age-related phenomenon is yet unknown. Jallat et al. (1993)
have shown that DAEC strains account for a large proportion of diarrhoea cases among
hospitalised patients in France who have no other identified enteropathogen. Other epidemiological
features and the true role of DAEC remain to be determined.
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3. AIMS OF THE PRESENT STUDY
The aims of this study were to:
-set up and use new molecular detection and typing methods for diagnosing and genotyping
diarrhoeagenic E. coli (EAEC, EPEC, ETEC and STEC);
-study the prevalence and (molecular) epidemiology of diarrhoagenic E. coli in diarrhoea in
Finland, and in diarrhoea associated with travel abroad. With diarrhoeas in Finland, special
emphasis was placed on STEC;
-compare the prevalence of diarrhoaegenic E. coli with that of conventional enteric pathogens.
This study was carried out at the Laboratory of Enteric Pathogens (LEP) of the National Public
Health Institute (Mannerheimintie 166, FIN-00300 Helsinki, Finland).
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4. MATERIALS AND METHODS
4.1 Subjects and specimens (I, II, III, IV, V)
The number of subjects and faecal specimens (samples or cultures) investigated in the different
parts of the study are presented in Table 2.
Table 2. Number of subjects with or without diarrhoea, and the faecal cultures available for
investigation
____________________________________________________________
Study Subjects           Faecal samples/cultures                 
Diarrhoeal Non-diarrhoeal
____________________________________________________________
 I 1 1 0
 II 481 481 0
 III 1 1 0
 IV 204 65 219
 V 603 603 92
_____________________________________________________________
4.2 Study design (II, IV, V)
4.2.1 Collection of samples and strains (II, V)
The diarrhoeal samples and STEC strains used in this study were collected at LEP in four phases.
January 1990-January 1996. The diagnosis of STEC infections in Finnish clinical microbiology
laboratories (in total 29) was based on rather occasional culturing of stools on Sorbitol
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MacConkey agar (SMAC) and isolation of sorbitol negative colonies. The pure cultures of these
colonies were sent to LEP on a voluntary basis. From 1994 on, these laboratories were obliged to
send all STEC O157:H7 isolates to LEP on the basis of regulations issued by the Ministry of
Social Affairs and Health. The strains were stored in skimmed milk at -70°C until use.
February 1996-January 1997. The clinical microbiology laboratories of 20 acute-care hospitals
culturing stool samples were approached by a letter providing diagnostic services free of charge for
potential STEC or other diarrhoeagenic E. coli infections in all patients with bloody diarrhoea. For
this purpose, these laboratories were asked to send the primary SMAC or Cystine-Lactose
Electrolyte-Deficient (CLED) agar plates cultured from stool samples of these patients by mail to
LEP.
Additionally, 122 stool cultures from consecutive diarrhoeal patients without macroscopically
visible blood in their stools were investigated. These samples were cultured in a hospital in the
central part of Finland (samples taken 7 January, 1997 – 21 February, 1997) and were
investigated at LEP for diarrhoeagenic E. coli.
February 1997-December 1997.  After the enhanced surveillance period, the service to examine
stx genes from stool cultures was offered to all 29 clinical microbiological laboratories in Finland in
cases where the patient was hospitalised for bloody diarrhoea or a suspected STEC infection. The
methods used at LEP were the same as used previously.
4.2.2 Setting for TD study (IV)
The Ethical Committee of the Finnish National Public Health Institute (KTL) approved the study
protocol. A charter-flight on an aircraft with 320 seats had been booked for a whole journey
round the world. An introductory letter was sent via the travel agent to all the tour participants. The
study was carried out among those 204 travellers who agreed to participate. They travelled round
the world (Helsinki, Finland [April 19] - Shanghai, China [April 20-22] - Kuching, Malaysia [April
22-24] - Sydney, Australia [April 24-27] - Fiji [April 27-30]- Santiago de Chile, Chile [April 30-
May 2]- Recife, Brazil [May 2-4]- Helsinki, Finland [May 5]) within 16 days in spring 1996. Each
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volunteer received two doses of the ETEC/recombinant B-subunit oral vaccine (SBL Vaccine Ab,
Stockholm, Sweden) (Jertborn et al. 1992, Sanchez et al. 1993) or a placebo containing heat-
killed E. coli K-12 suspended in phosphate buffered saline. The first dose was to be ingested
about 21 days before the trip, the second dose two weeks after the first dose. All participants gave
at least two fresh faecal samples: one immediately before and one after the trip. In addition, if
diarrhoea occurred during the journey, a faecal sample was collected as soon as possible and
another sample on the following day. Also, if diarrhoea occurred within a week after the return
home, a sample was taken. Additionally, a sample for parasitology was taken four weeks after the
return.
4.2.3 Controls (IV, V)
Stool samples taken from 92 Finns without diarrhoea before they left for a round-the-world trip
(cultured at LEP on April 19, 1996) formed the comparison group (Table 2).
4.3 Culturing and identification of diarrhoeal bacteria (I, II, III, IV, V)
All stool samples were cultured for Salmonella, Shigella, Campylobacter, Yersinia, Aeromonas
and Plesiomonas species by standard methods (Murray et al. 1995) in hospital laboratories
(samples from diarrhoeal patients) and at LEP (samples from healthy controls, subjects on return
and with TD). For detecting E. coli, nonselective SMAC or CLED plates were used.
4.4 Polymerase Chain Reaction (PCR) (I, II, III, IV, V)
Investigation of diarrhoeagenic E. coli was done with PCR. Genes detected, oligonucleotide
primers and optimiced reaction conditions used for PCR are presented in Table 3. For PCR, a
loopful of gram-negative bacterial growth, taken from the first streaking area of the primary faecal
culture plate, was suspended in 0.5 ml of sterile distilled water and boiled for 20 minutes. Selected
primer sequences matched completely with only the corresponding genes of corresponding E. coli
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pathoroups in GenBank/EMBL database libraries. The oligonucleotides used as primers were
purchased from Pharmacia Biotech (Uppsala, Sweden). In PCR amplification, all protocols used
(Table 3) included denaturation steps at 95°C, amplification steps with 30 amplification cycles and
final elongation steps at 72°C. The positive controls are presented in Table 3, and the negative
controls used were sterile distilled water and E. coli strain ATCC 25922.
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Table 3. Primers, amplification protocols and positive controls used for PCR
______________________________________________________________________________________________________________________
Target Primer sequence Amplicon size Reference of primers Reaction Controls
5’                                               3’ (bp)   conditions (°C) (Reference)
______________________________________________________________________________________________________________________
STEC CAGTTAATGTGGTGGCGAAG 894 Olsvik and Strockbine 1993 95°, 95°, 60°, 72°, 72° ATCC 43894,
/stx1 CTGCTAATAGTTCTGCGCATC 10',   1'      1'     1',   5' RH 3536
STEC CTTCGGTATCCTATTCCCGG 478 Olsvik and Strockbine 1993 95°, 95°, 60°, 72°, 72° ATCC 43894,
/stx2 CGATGCATCTCTGGTCATTG 4.5',  1'     1'     1',   5' RH 3536
EPEC TGCGGCACAACAGGCGGCGA 629 Heuvelink et al. 1995 95°, 95°, 72°, 72° RH 4283
/eae CGGTCGCCGCACCAGGATTC 5',     1'     1',    5' (=EPEC E2348/69)
(Baldini et al. 1990)
EAEC CTGGCGAAAGACTGTATCAT 630 Schmidt et al. 1995 95°, 95°, 62°, 72°, 72° RH 4260
CAATGTATAGAAATCCGCTGTT 5',    1'      1'     1',  10' (=E. coli 17-2)
(Baydry et al. 1990)
ETEC TCTCTATATGCACACGGAGC 321 Olsvik and Strockbine 1993 95°, 95°, 62°, 72°, 72° ATCC 35401,
/LT CCATACTGATTGCCGCAAT 5',    1'     1'     1',  10' ATCC 43886
TCTCTATGTGCATACGGAGC
ETEC TCTGTATTGTCTTTTTCACC 186 Frankel et al. 1989 95°, 95°, 62°, 72°, 72° ATCC 35401
/ST TTAATAGCACCCGGTACAAGC 5',    1'     1'     1',  10’
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4.5 Isolation and identification of E. coli (I, II, III, IV, V)
From the PCR-positive primary faecal culture, distinct E. coli-like and other gram-negative
colonies were isolated and tested for the presence of the sequence which had initially given a
positive result. As many colonies as required (however, no more than 100) for finding the isolate
carrying these particular genes were assayed. The isolates were subsequently characterised
biochemically by Api 20 E  (bioMerieux sa, Marcy l’Etoile, France). Their ability to ferment
sorbitol was also tested on SMAC. The PGUA test was executed according to the manufacturer's
instructions (AS Rosco, Taastrup, Denmark).
4.6 Serotyping of the isolates (I, II, III, IV, V)
O grouping was carried out by bacterial agglutination (Ørskov and Ørskov 1984) with antisera
against “traditional EPEC” (O26, O44, O55, O86, O111, O112, O114, O119, O124, O125,
O126, O127, O128 and O142) and other O groups (O1, O2, O4, O6, O7, O8, O9, O11, O15,
O16, O18, O22, O25, O50, O75, O77, O83, O85, 086, O100 and O157) (Siitonen 1992). A
strain giving clumping with 4% saline was defined as rough. Flagellar H antigens were identified by
agglutination of motile strains with seven anti-H serum pools (Ratiner 1989), capable of identifying
single E. coli flagellar antigens (anti-O and anti–H sera were kindly provided by Dr. Yuli Ratiner
from Mechnikov Research Institute for Vaccines and Sera, Moscow, Russia). A strain which did
not grow through semi-solid agar within a week was defined as nonmotile (HNM), and a strain
which was nontypable after six passages through semi-solid agar tubes was defined as nontypable
(HNT). In Work II, the presence of capsular polysaccharide was determined by a rocket
immunoelectrophoresis modification (Kuusi 1990) of precipitation with cetrimide (Cetavlon®,
Sigma Chemical Co, St Louis, USA) after gel electrophoresis of K antigen extracts (Ørskov
1976). A strain not reacting with cetrimide was defined as noncapsulated (K-). STEC strains which
were ONT (O-nontypeable) with any of the antisera in use at LEP were sent for typing to the
International Escherichia and Klebsiella Centre of the WHO at the Statens Seruminstitut
(Copenhagen, Denmark) (II).
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4.7 Detection of enterohaemolysin (Ehly) (I, II, III)
The production of Ehly was detected on a tryptose agar plate (Difco Laboratories, Detroit, USA)
supplemented with 10 mM CaCl2 and defibrinated sheep blood washed three times in phosphate-
buffered saline, pH 7.2 (Beutin et al. 1989). Blood agar with unwashed sheep blood was used as a
comparison plate. The plates were grown overnight in ambient air at 37°C. A halo around the
colonies on the plate with washed blood cells only was interpreted as Ehly positive.
4.8 Shigatoxin production (I, II, III)
The ability of an isolate to produce Stx1 and/or Stx2 toxin was determined by the reversed passive
latex agglutination test (Verotox F, Denka  Seiken, Tokyo, Japan) according to the manufacturer's
instructions; the test allowed toxin titers to a dilution of 1:128.
4.9 Antimicrobial susceptibility (II)
Antimicrobial susceptibility of the isolates was studied by the disk diffusion technique on Iso-
Sensitest medium, using the zone size criteria recommended by the disk manufacturer and based
on breakpoints established by the Swedish reference group for antibiotics (1990). The following
antimicrobial agents (AS Rosco, Taastrup, Denmark) were used: ampicillin; ceftriaxone;
chloramphenicol; ciprofloxacin; imipenem; mecillinam; nalidixic acid; neomycin; streptomycin;
sulphonamide; tetracycline; and trimethoprim.
4.10 Pulsed-field gel electrophoresis (PFGE) (II, IV)
Bacterial cells were grown on Luria-agar overnight in ambient air at 37°C. They were suspended
in 5 ml of TEN-buffer and were partially embedded in low-melting-temperature agarose
(SeaPlaque agarose, FMC BioProducts, Rockland, USA), and were digested overnight with
Proteinase-K (Boehringer Mannheim, Mannheim, Germany) at 55°C. The plugs were first washed
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for 30 minutes with TE buffer, then for 60 minutes with TE plus 200 µl of 100 mM phenyl
methanolsulphonyl fluoride and finally with TE three times for 30 minutes. Restriction endonuclease
digestion was done with 10 U of XbaI (Boehringer Mannheim, Mannheim, Germany) overnight at
37°C. PFGE was performed using Bio-Rad GenePath™ System in 1% agarose gel in 0.5x TBE
buffer at 14°C, a linear ramp of 2.20 to 54.20 seconds over a period of 22 hours, a 120-degree
switch angle, and a gradient of 6.0 V per cm. After PFGE, the gels were stained with ethidium
bromide and were photographed under UV transillumination.
In Work II, an isolate with at least two differences in the banding pattern among bands larger than
100 kb, was regarded as belonging to another subtype. Each subtype was given a number within a
serotype: serotype O157:H7 isolates were numbered 1a, 1b,  etc., isolates of serotype O26:H11
were 2a, 2b etc. In Work V, a different letter was assigned (A, B, C...) to each different PFGE-
type (Tenover et al. 1995), to indicate its dissimilarity to other isolates.
4.11 Characterisation of LPS with SDS-PAGE (III)
The technique described previously was used for the deproteinisation of bacterial whole cell
samples (Hitchcock and Brown 1983) Two E. coli O157:H7 strains (ATCC 43894, RH 1438)
were used as controls. The samples were electrophoresed through 12 % sodiumdodecylsulphate-
polyacrylamide gel (SDS-PAGE) as described by Laemmli (1970).
4.12 Determination of antibodies (III)
Agglutinins in the serum of the patient against boiled O157 antigen were titrated in wells of a
microtiter plate (Titertek®, Flow Laboratories, UK) using the Widal reaction method (Farmer
1995). The known positive, taken in the acute phase of O157 infection, and negative human sera
(tested previously at the Public Health Laboratory Service, Colindale Avenue, London, UK) were
used as controls.
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4.13 Virology and parasitology (IV)
The investigation for rotaviral and adenoviral antigens in samples from diarrhoeal patients was
carried out during the round-the-world trip by latex agglutination (Diarlex Rota-Adeno Kit, Orion
Diagnostica, Espoo, Finland) according to the manufacturer’s instructions. The specimens for
parasitology were collected before the trip and four weeks after the return, and were analysed at
the Unit of Parasitology of Helsinki University Central Hospital, Helsinki. The standard formalin-
ether concentration method was used (Murray et al. 1995).
4.14 Statistical methods (IV, V)
Differences between the cases and controls were compared using Fisher’s exact test (Epi-Info
6.04 software; WHO, Geneva, Switzerland and CDC, Atlanta, USA). P-values lower than 0.05
were considered significant.
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5. RESULTS
Publications I - V contain the results in detail.
5.1 Demographic characteristics of the subjects (I - V)
The ages of the 668 diarrhoeal patients (I - V) ranged from 0 to 98 years, and the ages of subjects
without diarrhoea from 15 to 76 years (IV, V) (Table 4). The gender distribution was similar in all
groups of subjects. Information about possible stays abroad before (maximum 2 weeks) the onset
of symptoms was available for 266 of the 603 diarrhoeal patients (V).
Table 4. Demographic characteristics of the subjects
_______________________________________________________________________
Number Symptoms2) Male/Female       Age(years)               Publication
of subjects range        mean     median
________________________________________________________________________
481 Bd 252/2233) 0 - 98 37 37 I, II, III,V
122 D 59/63  0 - 88 42 42 V
2041) 99/105 17-86 64 61 IV
651) D 34/31 45-86 63 62 IV
921) Nd 47/45 29 - 85 61 62 IV, V
________________________________________________________________________
1) 65 and 92 are subsets of the 204 subjects, 2) Bd=bloody diarrhoea, D=diarrhoea, Nd=no
diarrhoea, 3) No gender information was available for six subjects
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5.2 Diarrhoaegenic E. coli and other bacterial findings in faeces of Finns with diarrhoea
(I, II, III, V)
5.2.1 Findings of EPEC and EAEC in diarrhoea and characteristics of the isolates (V)
EPEC infection was detected by PCR in 19 (3.2%) and EAEC infection in six (1.0%) of the 603
diarrhoeal patients (Figure 2). Four EPEC infections were associated with trips abroad (Egypt
(two cases), Ghana and Peru). Four EAEC patients had visited in the Dominican Republic, Egypt,
Ghana and Kenya.
Figure 2. Findings of diarrhoeagenic E. coli in faecal samples from 603 subjects and findings of
other enteric bacterial pathogens in samples from 506 subjects with diarrhoea. The findings in
samples from 92 subjects formed the control group.
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Seventeen of the 19 EPEC (89.5%) and all seven EAEC (100%) isolares were available for
subtyping; only two of them could be characterised for their O groups (O15 and O55). In H
typing, most of the EPEC or EAEC isolates had a distinct H antigen. In PFGE, digestion of
chromosomal DNA with XbaI yielded 7 to 12 bands for EPEC and 10 to 12 bands for EAEC
(Figure 3). All EPEC and EAEC isolates showed different PFGE patterns when compared
visually.
Figure 3. Schematic view of PFGE patterns of EPEC (IH 110148 – IH 56794) and EAEC (IH
56820 – IH 110164) isolated from Finns with or without diarrhoea
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5.2.2 Findings of STEC isolated in Finland 1990-1997 (I, II, III)
Before the enhanced surveillance was started in 1996, only four sporadic infections caused by
STEC O157:H7 were diagnosed in Finland in the 1990s. During the enhanced surveillance 1996-
1997, eight infections were discovered, three caused by O157:H7 and five by non-O157 strains.
Of these, two represented unique STEC serotypes (OX3:H21 and Rough:H49) and caused HUS.
After the enhanced surveillance period, 59 STEC infections were detected. Of these, two STEC
O157:H7 infections resulted in deaths of the patients.
Of all 71 STEC isolates detected in Finland during 1990-1997, 57 were sorbitol and PGUA
negative and belonged to the O157:H7 serotype. One additional O157 strain was HNM, sorbitol
and PGUA positive. Of the 14 non-O157:H7 strains, STEC serotype O26:H11 was the most
common and was found in four patients. Of the 71 STEC strains, 63 carried the stx2 gene only,
five isolates (all O26) carried the stx1 gene only, and three isolates (all O157) carried both genes
(Figure 4). The eae gene was detected in all other isolates except five isolates of serotypes
O2:H29, O91:H121, O107:H27, OX3:H21 and Rough:H49. Production of Ehly was detected in
all but eight STEC isolates, all representing non-O157:H7 serotypes. Isolates found 1996 and
before were all of different genotypes. Four distinct genomic subtypes were found among STEC
O157:H7 strains isolated in 1997.
Figure 4. Comparison of STEC O157:H7 and non-O157:H7 isolates
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All isolates belonging to the serotype with more than one isolate (57 O157:H7 and 4 isolates of
O26:H11) were subtyped with PFGE. Digestion of chromosomal DNA with XbaI yielded 12 to
17 bands. Seven distinct genomic profiles could be seen among the 57 O157:H7 isolates and three
distinct profiles among the four O26:H11 isolates. Type 1a was the most common genotype found
among 36 (65%) of the O157:H7 strains. All 15 strains isolated in July 1997 in western Finland
had this 1a type PFGE pattern. Other common O157:H7 subtypes were 1b (n=7), 1c (n=6) and
1d (n=4). These subtypes were associated with sporadic cases of infection or with cases of
infection occurring within a family.
Table 4.  Characteristics of human STEC isolates in Finland, 1990 to 1997
______________________________________________________________________
Phenotype Virulence PFGE-genotypes Number of strains
determinants (number of isolates)
______________________________________________________________________
O157:H7, sor- stx2, eae, Ehly 1a (36), 1b (7), 1c (5)
1d(4), 1e (1), 1g (1) 55
O157:H7, sor- stx1 + stx2, eae, Ehly 1c (1), 1f (1) 2
O157:HNM, sor+ stx2, Ehly - 1
O26:H11, sor+ stx1, eae, Ehly 2a (2), 2b (1), 2c (1) 4
O26:HNM, sor+ stx1, eae - 1
Rough:H49, sor+ stx2 - 1
O2:H29, sor+ stx2 - 1
O91:H21, sor+ stx2, eae - 1
O91:H40, sor+ stx2, eae - 1
O101:HNM, sor+ stx2, eae - 1
O107:H27, sor+ stx2 - 1
O165:H25, sor+ stx2, eae, Ehly - 1
OX3:H21, sor+ stx2 - 1
______________________________________________________________________
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5.3 Findings associated with a round-the-world trip of Finns (IV)
During the trip in April 1996, diarrhoeal episodes took place in two peaks; the first occurred two
and the second 18 days after the departure (Figure 4). This second peak appeared one day after
the return to Finland. A stool sample was available for culture from 65 episodes of diarrhoea (60
subjects; 80% of all 75 patients with diarrhoea and 72% of all 90 diarrhoeal episodes). The causes
of the diarrhoeal episodes in China and Malaysia remained mostly unknown. The episodes in the
latter part of and after the trip probably originated in South America.
Figure 4. Onset and etiology of diarrhoeal episodes during and after a round the world trip
Three of the 92 stool samples taken from non-diarrheal subjects before the trip were positive for
potential enteric pathogenic bacteria (EAEC, STEC, Aeromonas sp.). Of these samples,
compared with the findings from 65 diarrhoeal samples, significant differences were found in EPEC
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(0/92 vs. 13/65; P< 0.001) and S. enterica (0/92 vs. 8/65; P< 0.001). In 65 diarrhoeal episodes,
enteropathogenic bacteria were found in 62%. The corresponding figure for the 127 subjects
without diarrhoea, healthy returnees, was 33% (P < 0.001). Of the 65 diarrhoeal episodes,
various pathogenic E. coli were found in 35% (23/65) and of the samples of the healthy returnees
in 26% (33/127) (P=NS). In 13 diarrhoeal episodes, they were a single pathogen and in 10, they
were found as a mixed culture with some other bacterial pathogen. The numbers of single E. coli
findings from diarrhoeal episodes and from healthy returnees did not differ statistically.
Figure 5. Bacterial findings in stool samples from diarrhoeal episodes of subjects (n=65) and from
healthy returnees (n=127). Findings from diarrhoeal episodes with several bacterial pathogens are
included in each column.
Non-ETEC strains were found in 29% (n=19) of the episodes: the eaeA-positive EPEC was
found in 26% (n=17) accompanied by EAEC in 8% (n=5) (Figure 5). The ST-toxin encoding gene
of ETEC was found in three and LT in one of the diarrhoeal episodes. All of the four episodes
(6%) caused by ETEC were episodes that started during or after a stay in South America.
Because the number of ETEC strains identified was low, the efficacy of the vaccine could not be
evaluated.
0
5
10
15
20
25
EP
EC
EA
EC
ET
EC
ST
EC
Sa
lm
on
ella
 en
teri
ca
Ca
mp
ylo
bac
ter 
sp.
Ae
rom
ona
s sp
.
Ye
rsin
ia s
p.
Sh
ige
lla 
sp.
Ple
sio
mo
nas
 sp
Mu
ltip
le p
ath
oge
ns
Findings
%
Diarrhoeal samples(n=65)
Helthy returnees(n=127)
Pre-trip samples(n=92)
45
Several bacterial pathogens were detected in 20% (n=13) of the diarrhoeal episodes (Figure 5),
whereas in specimens of 127 healthy subjects several pathogens were found on return in 2% (n=3,
P= <0.001). Of these three latter findings, all were EPEC in combination with either Aeromonas
sp., Salmonella or STEC. Of all bacterial findings, EPEC strains were the most common,
independent of the clinical picture of the subjects, detected in a total of 39 samples, whereas
Salmonella enterica was more commonly found as a single pathogen in diarrhoeal episodes than
in samples from healthy returnees (12% vs. 2%; P=0.005). The numbers of single non-E. coli
findings in diarrhoeal episodes and in healthy returnees differed significantly (22% vs. 7%;
P=.003).
5.4 Conventional enteric pathogens in patients with diarrhoea and in subjects travelling
around-the-world (IV, V)
In patients with diarrhoea (V), the results of the stool cultures for non-E. coli enteric pathogens
were available for 506 of the 603 patients with diarrhoea (83.9%). Other enteric bacterial
pathogens were found in 34 (6.7%) of these 506 patients. Campylobacter jejuni/coli was the
most common finding, isolated from 19 patients (3.8%) (16 C. jejuni, 3 C. coli infections) (Figure
5). In two of these cases, both EPEC and C. jejuni were detected in the same patient.
Salmonella enterica was found in ten (2.0%) patients. Yersinia enterocolitica was found in four
patients and Aeromonas sp. in one. Of these 34 patients, travel histories were known for 28, of
whom 16 (57.1%) had travelled abroad before becoming ill.
In patients during or after the round-the-world trip (IV), strains of various Salmonella serotypes
were the most common non-E. coli pathogens (Figure 5). They were isolated either alone or with
another bacterial pathogen in 24% (n=14) of the diarrhoeal episodes and in 3% (n=4) of the
healthy returnees (P=0.003). No rotaviral or adenoviral antigens were detected in diarrhoeal
patients.
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6. DISCUSSION
6.1 General aspects
Infectious diarrhoeal diseases contribute a considerable problem globally and are responsible for
considerable morbidity and mortality, especially in the developing countries (WHO 1993).
Diarrhoea also remains an important problem in the industrialised countries, but the course of the
disease is generally mild, and the mortality has decreased drastically over time (Cravioto et al.
1998). However, economic losses due to the cost of medical care and the absence of patients
from work or school may be considerable. Moreover, the numbers of diarrhoeal outbreaks have
increased during recent years in the industrialised countries (Armstrong et al. 1996). Recently it
was concluded that 20% of Britons had infectious intestinal disease each year (Wheeler et al.
1999). In Finland, the numbers of outbreaks associated with food and water increased during the
whole 1990s (Kukkula 1998).
Rapid and reliable detection and typing methods are required for successful microbiological
surveillance and investigation of infectious diseases. Traditionally, pathogenic bacteria from stools
have been analysed using conventional culturing methods and various animal models, which are
time-consuming and laborious but still widely in use today. However, DNA based detection
methods have become more and more common in clinical microbiology. They enable the analysis
to be done within 24 hours, or even within one working day, and provide more specific detection
of the desired organism (Nataro and Kaper 1998).
In this study, PCR was used to for detecting diarrhoaegenic E. coli. PCR, without enrichment
steps, will recognise culturable, viable but nonculturable, and even nonviable cells. Thus, the
inability of PCR discriminate between living and dead cells has been considered a negative aspect.
However, the detection of diarrhoaegenic E. coli in this study was done from stool cultures i.e. all
E. coli findings made were actually alive, and therefore potentially capable of causing symptoms.
In this study, before a round-the-world trip, few subjects carried any potential enteric pathogens,
whereas, on return of the subjects from the trip, a high number of subjects carrying various
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pathogenic E. coli non-symptomatically was found. This is not surprising, since in many developing
countries this kind of carriage of EPEC, EAEC or ETEC is common (Nataro and Kaper 1998).
Also, the high sensitivity of the PCR assay and the high infectious dose of these bacteria may
explain the nonsymptomacy of the subjects to whose normal microbial flora these bacteria do not
belong. Molecular methods, especially PCR, are nowadays considered the most reliable and
sensitive techniques for differentiating diarrhoeagenic E. coli strains from nonpathogenic members
of the stool flora, and for distinguishing one E. coli pathogroup from another (Nataro and Kaper
1998, Caeiro et al. 1999). In practice, PCR was a rapid and constant method for investigating
diarrhoeal samples. This was confirmed with stx PCR, as practically all strains isolated were also
Stx-producing when tested by another method (Verotox-F, Denka  Seiken, Tokyo, Japan). There
is no doubt that in the near future, PCR based detection methods will play a larger role in clinical
microbiology laboratories.
PFGE was used for genotyping E. coli isolates in this study. PFGE was capable of discriminating
between the strains within a single serotype and, therefore, confirmed whether isolates were related
or not. PFGE has become a standard tool in molecular epidemiology (Mickelsen 1997). It has
been stated that routine surveillance by this technique can identify outbreaks that are not detected
by traditional phenotypic methods and can ascertain whether a sudden increase in reported cases
is due to sporadic isolated cases or an outbreak (Nataro and Kaper 1998). In the USA, in the
PulseNet, PFGE patterns of STEC O157:H7 can be electronically transmitted to a databank at the
CDC, where they are automatically compared with patterns of other isolates. If the patterns
submitted by laboratories at different locations during a defined time period are found to match, the
CDC computer will alert of a possible outbreak (Centers for Disease Control 2001). PFGE is a
valuable tool in epidemiological research. However, the disadvantage of PFGE is that it is a slow,
labour- and equipment-intensive method. If shorter protocols are not developed, it is hard to
expect wider use of PFGE outside the research and reference laboratories.
6.2 Prevalence of diarrhoeagenic E.  coli in diarrhoea in Finland
Stool samples of 603 patients with sporadic diarrhoea were investigated by PCR for
diarrhoeagenic E. coli. Diarrhoeagenic E. coli were detected in 5.5% of the 603 patients with
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diarrhoea. EPEC were the most common diarrhoaegenic E. coli, found in 3.2% of the patients. In
four of these cases, EPEC was found together with other pathogens. EAEC and STEC infections
were both discovered in eight patients (1.3%). In practice, specific E. coli strains were isolated
from all PCR positive stool cultures; this indicates their significant prevalence in E. coli flora in
diarrhoeal stools. In a large recent Swedish study (Svenungsson et al. 2000), 5% of diarrhoeas in
adult patients were caused by STEC, EPEC or EAEC. The Swedish results are in accordance
with the present results. Also, in the present study, the mean age of the patients was about 40
years, indicating that diarrhoeagenic E. coli causes diarrhoea in adults in Finland, as well as in
Scandinavia, and probably also in other industrialiced countries.
Among the 506 of 603 patients regarding whom all conventional bacterial findings were available,
a non-E.coli pathogen was identified in 6.7%. Campylobacter sp. and Salmonella sp. were the
most common non-E. coli pathogens, found in 3.8% and 2.0% of the patients, respectively.
Salmonella sp. and Campylobacter sp. were also the most common non-E. coli pathogens found
in a recent study in Sweden (Svenungsson et al. 2000). However, in that study, Salmonella sp.
and Campylobacter sp. were found in total of 20% of the patients, a figure which is notably higher
than in our study. This difference might be due to different sampling areas. In the Swedish study, all
samples were gained from one hospital serving people in southern and western parts of Stockholm,
whereas in our study, the samples were collected from 16 hospitals all around Finland.
By the conventional serotyping, only one (O55) of the 17 EPEC isolates could be classified under
a traditional scheme of EPEC serotypes, suggesting that this old serotypic classification of
"dyspepsiekoli" is evidently not valid. This was also concluded in a recent Japanese report (Sunabe
and Honma 1998) investigating the relation between O serogroup and pathogenic factor genes in
E. coli, and in another report (Ansaruzzaman et al. 2000) on the clonal groups of EPEC
associated with diarrhoae in Bangladesh. Moreover, Vidotto et al. (2000) studied EPEC
associated with infant diarrhoea in Brazil. They concluded that virulence characteristics of EPEC
may be found in strains not belonging to the classical EPEC serotypes, and that molecular
identification is required for studying the epidemiology of diarrhoea suspected to be caused by E.
coli.
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6.3 STEC infections in Finland
6.3.1 Overall situation
The number of identified STEC infections in Finland was very low at the beginning of the 1990s.
The four sporadic O157:H7 infections were the only STEC detected during a 6-year period (1990
to 1995). After the first Scandinavian epidemic in Sweden in 1995 (Andersson and de Young
1996), LEP started an enhanced microbiological surveillance study of patients with bloody
diarrhoea to evaluate the actual prevalence of STEC infections in Finland. During this study, three
O157:H7 and five non-O157 infections were diagnosed during that 12-month period. After this
surveillance, the incidence of STEC infections changed dramatically. In all, the rise in the number of
STEC infections was over 10-fold from 1996 to 1997. In July 1997, the first STEC outbreak in
Finland caused by STEC serotype O157:H7 started (Paunio et al. 1998). A total of 15
microbiologically confirmed STEC cases were found to be associated with this outbreak. These
cases still accounted for only 25% of all 61 STEC infections in Finland in 1997. Two infections
were fatal. In most cases, the sources of the infections remained unknown. The outbreak was
associated with swimming water (Paunio et al. 1998) and, in one case, the patient had drunk
unpasteurised milk produced on a neighbouring farm (Tast et al. 1998). During the whole 8-year
period, only 10 (14%) of all 71 STEC infections were associated with travel outside Finland.
6.3.2 Pheno- and genotypes
In total, there were seven different STEC O157:H7 genotypes found during 1990-1997. All
isolates known to be associated with the outreak in western Finland (Paunio et al. 1998) showed
identical PFGE patterns (genotype 1a). Several sporadic isolates from different parts of Finland,
isolated before, during, and after the outbreak, represented the same PFGE pattern, which
together represented 65% of the O157:H7 strains isolated. Yet, no connection or common source
has been found for these isolates. However, when Finnish human and bovine STEC O157:H7
isolates were compared by different subtyping methods, PFGE and phagetyping, the same
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subtypes were found, suggesting that these infections could be of animal origin (Keskimäki et al.
2000, Lahti et al. 2001).
All 57 O157:H7 isolates found during the study were negative by sorbitol fermentation. A
distinctive characteristic of the Finnish O157:H7 strains was that they had the eae gene and
produced Stx2 and Ehly but not Stx1. Subtyping of Stx2 produced by these strains could provide
useful information for epidemiological research. Similar Stx2-producing STEC O157:H7 strains
have been described previously in other European countries. Of the human STEC O157:H7
isolates, 89% (Heuvelink et al. 1995) and 100% (Pierard et al. 1999) were solely Stx2 producing
in the Netherlands and Belgium, respectively. In North America, STEC isolates typically produce
both Stx1 and Stx2 toxins (Advisory comm... 1995).
Of the 14 non-O157 isolates found, serotype O26:H11 was the most common type, with four
isolates; one further O26 strain was non-motile. All O26 isolates produced Stx1 and were eae-,
sorbitol- and Ehly-positive. STEC O26:H11 has also been the most common non-O157 serotype
found in some other European countries, for example, in Germany and Denmark (WHO 1997).
The production of only Stx1 appears to be typical of STEC O26:H11. In a British study, 70% of
STEC O26:H11 produced Stx1 only (Scotland et al. 1990). Moreover, in Germany and the
Czech Republic, Stx1-producing STEC O26:H11 were the exclusive type identified until 1994,
but after 1997, 71% of  STEC O26:H11 isolates have been Stx2-producing (Zhang et al. 2000).
Most other STEC strains produce Stx1 very rarely (Advisory comm… 1995, Zhang et al. 2000);
in the present study, except for the O26 strains, no such strain was found. The other non-O157
STEC strains detected in this study, were Stx2-producing and sorbitol-positive, but their
possession of the eae gene varied.
Two of the non-O157:H7 strains represented unpublished STEC serotypes (OX3:H21 and
Rough:H49) associated with HUS. These strains were Stx2-producing and eae-negative. In
Sweden, Rough-type STEC (STEC without O antigen) has been associated with HUS and bloody
diarrhoea (Welinder-Olsson et al. 2000). Since it is generally believed that loss of the O antigen of
bacteria results in loss of virulence (Nikaido 1996), these findings emphasise the need for further
research in STEC pathogenesis. Additionally, following our publications, STEC strains
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representing O-type OX3, many also Stx2-producing and eae-negative, have been commonly
found in France, from cattle and associated with HUS (Bonnet et al. 1998, Pradel et al. 2000),
and in Argentina, from cattle and ground beef (Parma et al. 2000). Nowadays, this serotype OX3
is called O174 (Scheutz 2000). All these STEC infections were sporadic and not associated with
travel abroad, suggesting their endemic prevalence in these countries, possibly in cattle.
6.4 Diarrhoeagenic E. coli associated with TD
Causes of TD are numerous, but bacteria, and especially ETEC, are believed to be its major cause
(Ericsson and DuPont 1993, Mattila 1995). In our prospective study, a group of 204 Finns
travelled round the world in 16 days. The incidence of diarrhoea was registered, and a stool
sample of each patient was taken and cultured immediately for E. coli during the course of the
journey. Rotaviruses and adenoviruses were also investigated immediately by a nurse or laboratory
technician who travelled with the group. Pathogenic E. coli was found in 35% of the 65 episodes
of diarrhoea but also often (26%) in the subjects without diarrhoea. Conventional enteric
pathogens (S. enterica, Campylobacter, etc.) were found in lesser amounts from diarrhoeal
episodes (22%) than diarrhoaegenic E. coli, as a group, and parasites or rota- and adenoviruses
were not found to be associated with diarrhoea.
ETEC has been regarded as the most common pathogen in TD, irrespective of the tourist
destination (Ericsson and DuPont 1993, Mattila 1995). However, during recent years, very few
studies have been made about the current aetiology of TD or diarrhoea in different countries.
Recently, ETEC was associated with three waterborne outbreaks on cruise ships (Daniels et al.
2000), and in a Dutch study, ETEC was found in 11% of returned travellers with diarrhoea
(Schultsz et al. 2000). In our study, ETEC strains were found in only four (6%) of all the 65
diarrhoeal episodes. ETEC detected in these subjects were from episodes that started after a stay
of 2-3 days in South American countries (Chile and Brazil). Thus, all ETEC detected in the
subjects probably originated in South America. Furthermore, ETEC has been reported to be a
common diarrhoeal pathogen in Brazil (Torniepoth et al. 1995). In the present study, although the
number of TD episodes was higher after a visit to South America than after visits to other places
previously, EPEC rather than ETEC was the major pathogroup of E. coli found in these diarrhoeal
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episodes. The same type of aetiology of diarrhoea, where EPEC, not ETEC, is the most prevalent
enteric pathogen, has been found also in other developing countries, e. g. Nigeria (Akinyemi et al.
1998).
In our study, EPEC strains were the most common finding both in diarrhoeal samples and in
samples taken from healthy subjects on return. EPEC was not found in pre-trip samples, and the
difference between the pre-trip samples and the diarrhoeal samples was significant. In a recent
Swedish study (Svenungsson et al. 2000), EPEC was detected in same numbers in both returning
diarrhoeatic travellers and healthy subjects. In developing countries, while nonsymptomatic
carriage of EPEC is common, it is still an important cause of infant diarrhoea. However, it has not
been traditionally implicated as a cause of TD (Nataro and Kaper 1998). In Brazil, one of the
countries visited during the present trip, EPEC has been the most prevalent enteropathogen in
diarrhoeal children (Rosa et al. 1998). In Nigeria, EPEC was also the most common
enteropathogen found in 27% of patients with acute diarrhoea (Akinyemi et al. 1998). In the
present study, the finding that EPEC was the most common E. coli pathogroup in stools of
diarrhoeal patients suggests that EPEC alone (15%), or together with another pathogen (9%), is
capable of causing TD, although nonsymptomatic carriage was also high (15%).
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7. SUMMARY AND CONCLUSIONS
Diarrhoea associated with bacterial infections is the most common illness experienced by millions
of people in developing countries, as well as the major cause of disease in international travellers.
The development of new molecular diagnostic methods has made it possible to re-evaluate the
prevalence of different diarrhoeagenic E. coli in diarrhoea. In this study, the aetiology of diarrhoea
was investigated among diarrhoeal patients in Finland during 1996-1997 and among adult Finnish
tourists participating in a round-the-world trip in April 1996. Special emphasis was placed on the
prevalence and characteristics of various diarrhoaegenic E. coli: STEC, EPEC, EAEC and ETEC.
In diarrhoeal patients in Finland, diarrhoeagenic E. coli, as a group, proved to be a more common
potential cause of diarrhoea than Salmonella sp. or Campylobacter sp. or any other enteric
bacterial pathogen commonly studied in cases of diarrhoea. Also, nonsymptomatic carriage of
diarrhoeagenic E. coli was found. This may reflect a need for further study to evaluate the
extension of this phenomenom and, moreover, to evaluate the significance of E. coli findings from
diarrhoeal patients. Nevertheless, although the new diarrhoeagenic E. coli groups, EAEC and
STEC, as well as the old group EPEC, were found at low frequencies in diarrhoeal stool samples
from patients of different ages, they were more prevalent and more often of domestic origin than
was expected. The annual incidence of detected STEC infections increased 10-fold during the
period of the study and the first STEC outbreak in Finland took place. Two children died of
serious illness caused by STEC. All these findings suggest that the contribution of diarrhoeagenic
E. coli is greater than is currently appreciated in Finland and, probably, in the industrialised world,
and therefore their study with appropriate methods is recommended.
In the genotyping of diarrhoeal E. coli isolates, all EPEC and EAEC strains isolated represented
different PFGE genotypes, suggesting that all cases were sporadic. These PFGE results indicate
that there are a large number of different EPEC and EAEC types that may cause diarrhoea in
humans. By the conventional O serotyping, only one of all EPEC isolates could be classified under
a traditional EPEC serotype (O55), suggesting that this serotypic classification of  “dyspepsiekoli”
no longer seems to be valid. The genotyping of STEC O157:H7 isolates showed that one type was
far more common than the others, but several other types were also found. The number of non-
54
O157 infections was consistent during the years when they were investigated. Moreover, unique
non-O157:H7 STEC associated with HUS were found, indicating the importance of detection all
STEC strains, not just sorbitol-negative O157:H7 strains.
The new molecular diagnostic methods made it possible to re-evaluate the causes of TD and also
made it possible to extend the analysis to new E. coli pathogroups. In this study, a new group,
EAEC, and an old group, EPEC, proved to be the major E. coli groups associated with TD,
whereas STEC and ETEC seemed to have only limited roles as causative agents.
The numbers of diarrhoeagenic E. coli and other enteric pathogens, found in diarrhoeal patients in
Finland and in subjects participating in a trip round the world, were very much alike.
Diarrhoeagenic E. coli, especially EPEC, was the most common pathogen found in both groups.
S. enterica and Campylobacter sp. were the most common non-E. coli pathogens found. The
only difference between the subject groups was the common asymptomatic carriage of
diarrhoeagenic E. coli among subjects returning from the round-the-world trip. All these results
could mean that, although the enteric bacterial pathogens found in patients with diarrhoea in Finland
and in the rest of the world seem to be similar in types and proportions, the incidence of these
bacteria still remains lower in Finland.
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